Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V Klück
P160 the First Phase 2A Proof-Of-Concept Study of a Selective NLRP3 Inflammasome Inhibitor, Dapansutrile™ (OLT1177™), in Acute Gout
P159/O30 OLT1177™, an Oral NLRP3 Inflammasome Inhibitor, Inhibits Acute Joint Inflammation and Circulating IL 1β During Gout Flares in Humans
Related publications
A Study Case in Photoepilation, the HPPL™ and IFL™ Technologies
Dermatology Reports
Dermatology
Students’ Perception on Their Motivation in Learning English (The Analysis Students’ Motivation Based on Maslow’s Concept)
Biormatika : Jurnal ilmiah fakultas keguruan dan ilmu pendidikan
Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof-Of-Concept, Single-Centre, Open-Label Phase 2a Cohort Study
The Lancet Infectious Diseases
Infectious Diseases
Does Colchicine Work? The Results of the First Controlled Study in Acute Gout
Australian and New Zealand Journal of Medicine
Cellular Localization of NLRP3 Inflammasome
Protein & Cell
Biochemistry
Biotechnology
Drug Discovery
Cell Biology
Medicine
Do Not €˜Hit and Miss’ or €˜Spray and Pray’, Diagnose First
Journal of Economics and Behavioral Studies
RORγ Regulates the NLRP3 Inflammasome
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A First in Human Study of the Selective Cardiac Myosin Inhibitor, CK-3773274
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology